Phase II

Sofpromed offers clinical trial management services for phase II studies in cancer across Europe and worldwide.

A phase II trial is a study that evaluates whether a new therapy is effective for a certain kind of cancer (efficacy is commonly measured by radiological tumor response, progression free survival or overall survival). Phase II clinical trials may also generate data regarding the safety of the drug and how the treatment affects the patient.

Our phase II services include regulatory affairs, site qualification, site management, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management.

 ← Early Phase                 Phase III  → 

Subscribe To Our Articles and Updates


You have Successfully Subscribed!